Global Darbepoetin Alfa Market Insights, Research Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 112

Report ID: 4232

Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
The classification of Darbepoetin Alfa includes Epogen, Procrit, Aranesp and others, and the proportion of Epogen in 2017 is about 45%.
Darbepoetin Alfa is widely used for Patients with Chronic Kidney Disease, Patients with Cancer others. The most proportion of Darbepoetin Alfa is used for the Patients with Chronic Kidney Disease, and the proportion in 2017 is 62%.
North America is the largest consumption place, with a consumption market share nearly 47% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 41%.
The global Darbepoetin Alfa market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Darbepoetin Alfa market based on company, product type, end user and key regions.

This report studies the global market size of Darbepoetin Alfa in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Darbepoetin Alfa in these regions.
This research report categorizes the global Darbepoetin Alfa market by top players/brands, region, type and end user. This report also studies the global Darbepoetin Alfa market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen 
Johnson & Johnson
Kyowa Hakko Kirin
Novartis
3SBio

Market size by Product
Epogen
Procrit
Aranesp
Others
Market size by End User
Patients with Chronic Kidney Disease
Patients with Cancer
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Darbepoetin Alfa market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Darbepoetin Alfa market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Darbepoetin Alfa companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Darbepoetin Alfa submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Darbepoetin Alfa are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Darbepoetin Alfa market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Darbepoetin Alfa Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Darbepoetin Alfa Market Size Growth Rate by Product
1.4.2 Epogen
1.4.3 Procrit
1.4.4 Aranesp
1.4.5 Others
1.5 Market by End User
1.5.1 Global Darbepoetin Alfa Market Size Growth Rate by End User
1.5.2 Patients with Chronic Kidney Disease
1.5.3 Patients with Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Darbepoetin Alfa Market Size
2.1.1 Global Darbepoetin Alfa Revenue 2014-2025
2.1.2 Global Darbepoetin Alfa Sales 2014-2025
2.2 Darbepoetin Alfa Growth Rate by Regions
2.2.1 Global Darbepoetin Alfa Sales by Regions
2.2.2 Global Darbepoetin Alfa Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Darbepoetin Alfa Sales by Manufacturers
3.1.1 Darbepoetin Alfa Sales by Manufacturers
3.1.2 Darbepoetin Alfa Sales Market Share by Manufacturers
3.1.3 Global Darbepoetin Alfa Market Concentration Ratio (CR5 and HHI)
3.2 Darbepoetin Alfa Revenue by Manufacturers
3.2.1 Darbepoetin Alfa Revenue by Manufacturers (2014-2019)
3.2.2 Darbepoetin Alfa Revenue Share by Manufacturers (2014-2019)
3.3 Darbepoetin Alfa Price by Manufacturers
3.4 Darbepoetin Alfa Manufacturing Base Distribution, Product Types
3.4.1 Darbepoetin Alfa Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Darbepoetin Alfa Product Type
3.4.3 Date of International Manufacturers Enter into Darbepoetin Alfa Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Darbepoetin Alfa Sales by Product
4.2 Global Darbepoetin Alfa Revenue by Product
4.3 Darbepoetin Alfa Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Darbepoetin Alfa Breakdown Data by End User

6 North America
6.1 North America Darbepoetin Alfa by Countries
6.1.1 North America Darbepoetin Alfa Sales by Countries
6.1.2 North America Darbepoetin Alfa Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Darbepoetin Alfa by Product
6.3 North America Darbepoetin Alfa by End User

7 Europe
7.1 Europe Darbepoetin Alfa by Countries
7.1.1 Europe Darbepoetin Alfa Sales by Countries
7.1.2 Europe Darbepoetin Alfa Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Darbepoetin Alfa by Product
7.3 Europe Darbepoetin Alfa by End User

8 Asia Pacific
8.1 Asia Pacific Darbepoetin Alfa by Countries
8.1.1 Asia Pacific Darbepoetin Alfa Sales by Countries
8.1.2 Asia Pacific Darbepoetin Alfa Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Darbepoetin Alfa by Product
8.3 Asia Pacific Darbepoetin Alfa by End User

9 Central & South America
9.1 Central & South America Darbepoetin Alfa by Countries
9.1.1 Central & South America Darbepoetin Alfa Sales by Countries
9.1.2 Central & South America Darbepoetin Alfa Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Darbepoetin Alfa by Product
9.3 Central & South America Darbepoetin Alfa by End User

10 Middle East and Africa
10.1 Middle East and Africa Darbepoetin Alfa by Countries
10.1.1 Middle East and Africa Darbepoetin Alfa Sales by Countries
10.1.2 Middle East and Africa Darbepoetin Alfa Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Darbepoetin Alfa by Product
10.3 Middle East and Africa Darbepoetin Alfa by End User

11 Company Profiles
11.1 Amgen 
11.1.1 Amgen  Company Details
11.1.2 Company Business Overview
11.1.3 Amgen  Darbepoetin Alfa Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen  Darbepoetin Alfa Products Offered
11.1.5 Amgen  Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Company Business Overview
11.2.3 Johnson & Johnson Darbepoetin Alfa Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Johnson & Johnson Darbepoetin Alfa Products Offered
11.2.5 Johnson & Johnson Recent Development
11.3 Kyowa Hakko Kirin
11.3.1 Kyowa Hakko Kirin Company Details
11.3.2 Company Business Overview
11.3.3 Kyowa Hakko Kirin Darbepoetin Alfa Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Kyowa Hakko Kirin Darbepoetin Alfa Products Offered
11.3.5 Kyowa Hakko Kirin Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Company Business Overview
11.4.3 Novartis Darbepoetin Alfa Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis Darbepoetin Alfa Products Offered
11.4.5 Novartis Recent Development
11.5 3SBio
11.5.1 3SBio Company Details
11.5.2 Company Business Overview
11.5.3 3SBio Darbepoetin Alfa Sales, Revenue and Gross Margin (2014-2019)
11.5.4 3SBio Darbepoetin Alfa Products Offered
11.5.5 3SBio Recent Development

12 Future Forecast
12.1 Darbepoetin Alfa Market Forecast by Regions
12.1.1 Global Darbepoetin Alfa Sales Forecast by Regions 2019-2025
12.1.2 Global Darbepoetin Alfa Revenue Forecast by Regions 2019-2025
12.2 Darbepoetin Alfa Market Forecast by Product
12.2.1 Global Darbepoetin Alfa Sales Forecast by Product 2019-2025
12.2.2 Global Darbepoetin Alfa Revenue Forecast by Product 2019-2025
12.3 Darbepoetin Alfa Market Forecast by End User
12.4 North America Darbepoetin Alfa Forecast
12.5 Europe Darbepoetin Alfa Forecast
12.6 Asia Pacific Darbepoetin Alfa Forecast
12.7 Central & South America Darbepoetin Alfa Forecast
12.8 Middle East and Africa Darbepoetin Alfa Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Darbepoetin Alfa Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer